Hepatitis B virus transmission by blood transfusion during 4 years of individual-donation nucleic acid testing in South Africa: Estimated and observed window period risk

Transfusion

Volumn 52, Issue 4, 2012, Pages 880-892

  Vermeulen, Marion ^a,b,c   Dickens, Caroline ^a,b,c   Lelie, Nico ^a,b,c   Walker, Evangelia ^a,b,c   Coleman, Charl ^a,b,c   Keyter, Mark ^a,b,c   Reddy, Ravi ^a,b,c   Crookes, Robert ^a,b,c   Kramvis, Anna ^a,b,c  

^a SOUTH AFRICAN NATIONAL BLOOD SERVICE   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c Lelie Research   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; VIRUS DNA;

ADULT; ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; CASE REPORT; DNA DETERMINATION; GENE SEQUENCE; GENOME ANALYSIS; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INFECTION RISK; MALE; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENETIC TREE; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; SOUTH AFRICA; VIRUS DIAGNOSIS; VIRUS GENOME; VIRUS ISOLATION; VIRUS LOAD; VIRUS STRAIN; VIRUS TRANSMISSION;

ACUTE DISEASE; BLOOD TRANSFUSION; DNA, VIRAL; HEPATITIS B; HUMANS; PHYLOGENY; RISK; SEQUENCE ANALYSIS, DNA; VIRAL LOAD;

EID: 84859779514     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2011.03355.x     Document Type: Article

References (44)

1. Vermeulen M, Lelie N, Sykes W, Crookes R, Swanevelder J, Gaggia L, Le Roux M, Kuun E, Gulube S, Reddy R,. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa. Transfusion 2009; 49: 1115-25.
2. Fang CT, Field SP, Busch MP, Heyns Adu P,. Human immunodeficiency virus-1 and hepatitis C virus RNA among South African blood donors: estimation of residual transfusion risk and yield of nucleic acid testing. Vox Sang 2003; 85: 9-19.
3. Heyns Adu P,. Risk of transmitting HIV and other diseases with a blood transfusion in South Africa. CME (South African Med Assoc) 1999: 854-61.
4. Kleinman SH, Lelie N, Busch MP,. Infectivity of human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion. Transfusion 2009; 49: 2454-89.
5. Zou S, Dorsey KA, Notari EP, Foster GA, Krysztof DE, Musavi F, Dodd RY, Stramer SL,. Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing. Transfusion 2010; 50: 1495-504.
6. Ferreira MC, Nel TJ,. Differential transmission of human immunodeficiency virus (HIV) via blood components from an HIV-infected donor. Transfusion 2006; 46: 156-7.
7. Inaba S, Ito A, Miyata Y, Ishii H, Kajimoto S, Tanaka M, Maruta A, Saito S, Yugi H, Hino M, Tadokoro K,. Individual nucleic amplification technology does not prevent all hepatitis B virus transmission by blood transfusion. Transfusion 2006; 46: 2028-9.
8. Phelps R, Robbins K, Liberti T, Machuca A, Leparc G, Chamberland M, Kalish M, Hewlett I, Folks T, Lee LM, McKenna M,. Window-period human immunodeficiency virus transmission to two recipients by an adolescent blood donor. Transfusion 2004; 44: 929-33.
9. Satake M, Taira R, Yugi H, Hino S, Kanemitsu K, Ikeda H, Tadokoro K,. Infectivity of blood components with low hepatitis B virus DNA levels identified in a lookback program. Transfusion 2007; 47: 1197-205.
10. Schmidt M, Korn K, Nubling CM, Chudy M, Kress J, Horst HA, Geusendam G, Hennig H, Sireis W, Rabenau HF, Doerr HW, Berger A, Hourfar MK, Gubbe K, Karl A, Fickenscher H, Tischer BK, Babiel R, Seifried E, Gurtler L,. First transmission of human immunodeficiency virus Type 1 by a cellular blood product after mandatory nucleic acid screening in Germany. Transfusion 2009; 49: 1836-44.
11. Wendel S, Levi JE, Biagini S, Candotti D, Allain JP,. A probable case of hepatitis B virus transfusion transmission revealed after a 13-month-long window period. Transfusion 2008; 48: 1602-8.
12. Liu CJ, Lo SC, Kao JH, Tseng PT, Lai MY, Ni YH, Yeh SH, Chen PJ, Chen DS,. Transmission of occult hepatitis B virus by transfusion to adult and pediatric recipients in Taiwan. J Hepatol 2006; 44: 39-46.
13. Kleinman SH, Busch MP,. Assessing the impact of HBV NAT on window period reduction and residual risk. J Clin Virol 2006; 36 Suppl 1: S23-9.
14. Komiya Y, Katayama K, Yugi H, Mizui M, Matsukura H, Tomoguri T, Miyakawa Y, Tabuchi A, Tanaka J, Yoshizawa H,. Minimum infectious dose of hepatitis B virus in chimpanzees and difference in the dynamics of viremia between genotype A and genotype C. Transfusion 2008; 48: 286-94.
15. Biswas R, Tabor E, Hsia CC, Wright DJ, Laycock ME, Fiebig EW, Peddada L, Smith R, Schreiber GB, Epstein JS, Nemo GJ, Busch MP,. Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection. Transfusion 2003; 43: 788-98.
16. Weusten J, Vermeulen M, van Drimmelen H, Lelie N,. Refinement of a viral transmission risk model for blood donations in seroconversion window phase screened by nucleic acid testing in different pool sizes and repeat test algorithms. Transfusion 2011; 51: 203-15.
17. Assal A, Barlet V, Deschaseaux M, Dupont I, Gallian P, Guitton C, Morel P, David B, De Micco P,. Comparison of the analytical and operational performance of two viral nucleic acid test blood screening systems: Procleix Tigris and cobas s 201. Transfusion 2009; 49: 289-300.
18. Assal A, Barlet V, Deschaseaux M, Dupont I, Gallian P, Guitton C, Morel P, van Drimmelen H, David B, Lelie N, De Micco P,. Sensitivity of two hepatitis B virus, hepatitis C virus (HCV), and human immunodeficiency virus (HIV) nucleic acid test systems relative to hepatitis B surface antigen, anti-HCV, anti-HIV, and p24/anti-HIV combination assays in seroconversion panels. Transfusion 2009; 49: 301-10.
19. Koppelman MH, Assal A, Chudy M, Torres P, de Villaescusa RG, Reesink HW, Lelie PN, Cuypers HT,. Multicenter performance evaluation of a transcription-mediated amplification assay for screening of human immunodeficiency virus-1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA in blood donations. Transfusion 2005; 45: 1258-66.
20. Matsumoto C, Tadokoro K, Fujimura K, Hirakawa S, Mitsunaga S, Juji T,. Analysis of HBV infection after blood transfusion in Japan through investigation of a comprehensive donor specimen repository. Transfusion 2001; 41: 878-84.
21. Soldan K, Barbara JA, Dow BC,. Transfusion-transmitted hepatitis B virus infection in the UK: a small and moving target. Vox Sang 2002; 83: 305-8.
22. Gerlich WH, Bremer C, Saniewski M, Schuttler CG, Wend UC, Willems WR, Glebe D,. Occult hepatitis B virus infection: detection and significance. Dig Dis 2010; 28: 116-25.
23. Allain JP, Belkhiri D, Vermeulen M, Crookes R, Cable R, Amiri A, Reddy R, Bird A, Candotti D,. Characterization of occult hepatitis B virus strains in South African blood donors. Hepatology 2009; 49: 1868-76.
24. Tsebe KV, Burnett RJ, Hlungwani NP, Sibara MM, Venter PA, Mphahlele MJ,. The first five years of universal hepatitis B vaccination in South Africa: evidence for elimination of HBsAg carriage in under 5-year-olds. Vaccine 2001; 19: 3919-26.
25. Cable R, Lelie N, Bird A,. Individual donation Testing (IDT) in the western Cape of South Africa using nucleic acid amplification technology (NAT): a 5 year review. Vox Sang Abstracts 2011; 101: 196-97.
26. Heermann KH, Gerlich WH, Chudy M, Schaefer S, Thomssen R,. Quantitative detection of hepatitis B virus DNA in two international reference plasma preparations. Eurohep Pathobiology Group. J Clin Microbiol 1999; 37: 68-73.
27. Saldanha J, Gerlich W, Lelie N, Dawson P, Heermann K, Heath A,. An international collaborative study to establish a World Health Organization international standard for hepatitis B virus DNA nucleic acid amplification techniques. Vox Sang 2001; 80: 63-71.
28. Takahashi K, Aoyama K, Ohno N, Iwata K, Akahane Y, Baba K, Yoshizawa H, Mishiro S,. The precore/core promoter mutant (T1762A1764) of hepatitis B virus: clinical significance and an easy method for detection. J Gen Virol 1995; 76 (Pt 12): 3159-64.
29. Gunther S, Li BC, Miska S, Kruger DH, Meisel H, Will H,. A novel method for efficient amplification of whole hepatitis B virus genomes permits rapid functional analysis and reveals deletion mutants in immunosuppressed patients. J Virol 1995; 69: 5437-44.
30. Kramvis A, Restorp K, Norder H, Botha JF, Magnius LO, Kew MC,. Full genome analysis of hepatitis B virus genotype E strains from South-Western Africa and Madagascar reveals low genetic variability. J Med Virol 2005; 77: 47-52.
31. Xia X,. Data analysis in molecular biology and evolution. Boston, MA, Dordrecht, London: Kluwer Academic Publishers; 2000.
32. Nicholas K, Nicholas HB, Deerfield DW,. GeneDoc: analysis and visualization of genetic variation. EMBNEW.NEWS 4:14 [monograph on the internet]. 1997. [cited 2011 Sep 15]. Available from: URL
33. Felsenstein J,. PHYLIP (Phylogenecy Inference Package). Department of Genetics. University of Washington, Seattle, Washington [monograph on the internet]. 1995. [cited 2011 Sep 15]. Available from: URL
34. Page RD,. TreeView: an application to display phylogenetic trees on personal computers. Comput Appl Biosci 1996; 12: 357-8.
35. Yoshikawa A, Gotanda Y, Itabashi M, Minegishi K, Kanemitsu K, Nishioka K,. HBV NAT positive [corrected] blood donors in the early and late stages of HBV infection: analyses of the window period and kinetics of HBV DNA. Vox Sang 2005; 88: 77-86.
36. Tabuchi A, Tanaka J, Katayama K, Mizui M, Matsukura H, Yugi H, Shimada T, Miyakawa Y, Yoshizawa H,. Titration of hepatitis B virus infectivity in the sera of pre-acute and late acute phases of HBV infection: transmission experiments to chimeric mice with human liver repopulated hepatocytes. J Med Virol 2008; 80: 2064-8.
37. Korelitz JJ, Busch MP, Kleinman SH, Williams AE, Gilcher RO, Ownby HE, Schreiber GB,. A method for estimating hepatitis B virus incidence rates in volunteer blood donors. National Heart, Lung, and Blood Institute Retrovirus Epidemiology Donor Study. Transfusion 1997; 37: 634-40.
38. Candotti D, Allain JP,. Transfusion-transmitted hepatitis B virus infection. J Hepatol 2009; 51: 798-809.
39. Kimbi GC, Kramvis A, Kew MC,. Distinctive sequence characteristics of subgenotype A1 isolates of hepatitis B virus from South Africa. J Gen Virol 2004; 85: 1211-20.
40. Guo WT, Bell KD, Ou JH,. Characterization of the hepatitis B virus EnhI enhancer and X promoter complex. J Virol 1991; 65: 6686-92.
41. Moolla N, Kew M, Arbuthnot P,. Regulatory elements of hepatitis B virus transcription. J Viral Hepat 2002; 9: 323-31.
42. Barker LF, Murray R,. Relationship of virus dose to incubation time of clinical hepatitis and time of appearance of hepatitis-associated antigen. Am J Med Sci 1972; 263: 27-33.
43. Allain JP,. Occult hepatitis B virus infection: implications in transfusion. Vox Sang 2004; 86: 83-91.
44. Yuen M, Wong D, Lee C, Yasuhit T, Allain JP, Fung J, Leung J, Lin C, Sugiyama M, Sugauchi F, Mizokami M,. Transmissibility of hepatitis B virus (HBV) infection through blood transfusion from blood donor with occult HBV infection. Clin Infect Dis 2011; 52: 624-32.